FindTrial
Sign In

observational study of immune status in patients with sepsis

observational study of immune status in patients with sepsis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17011816
Enrollment
Unknown
Registered
2017-06-30
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

sepsis group:no

Sponsors

Zhejiang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Meet the dignostic criteria of sepsis; 2. Patients or his/her family members sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients or family members do not agree to participate in the trial; 2. End stage of malignant tumor; 3. Age under 18; 4. A history of solid organs or bone marrow transplants; 5. Autoimmune disease; 6. Pregnant or lactating patients; 7. HIV infected patients.

Design outcomes

Primary

MeasureTime frame
ICU or 28th-day mortality;—

Secondary

MeasureTime frame
expression of mHLA-DR;the count and type of Lymphocytes (CD4+, CD8+);PCT;APACHE II;SOFA;—

Countries

China

Contacts

Public ContactYan Jin

Zhejiang Hospital

296066337@qq.com+86 18814882081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026